Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians

Diabetes Care

Volumn 26, Issue 12, 2003, Pages 3226-3229

  Snehalatha, Chamukuttan ^a   Mukesh, Bheekamchand ^a   Simon, Mary ^a   Viswanathan, Vijay ^a   Haffner, Steven M ^b   Ramachandran, Ambady ^a  

^a Diabetes Research Centre Tamil Nadu   (India)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY CONSTITUTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINS; TIME FACTORS;

EID: 0344844389     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.12.3226     Document Type: Article

References (20)

1. Saltiel AR: You are what you secrete. Nat Med 7:887-888, 2001
2. Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51-59, 2002
3. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M: Plasma Adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243, 2003
4. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Duchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141, 2002
5. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25:971-976, 2002
6. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in a Japanese population (Abstract). Diabetes 52 (Suppl. 1):A327, 2003
7. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet Res Lett 360:57-58, 2002
8. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH: Adiponectin and protection against type 2 diabetes mellitus. Lancet Res Lett 361:226-228, 2003
9. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition, visceral fat, leptin and insulin resistance in Asian Indian Men. J Clin Endocrinol Metab 84:1137-1144, 1999
10. Snehalatha C, Ramachandran A: Insulin resistance in Asian Indians. Prac Diab Inter 16:19-22, 1999
11. rd World Congress Prevention of Diabetes and its Complications: A Special WHO/IDF Workshop: Hong Kong, 29 September to 1 October 2002. A0122:P35, 2002
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
14. Hanley A, Connelly P, Harris S, Zinman B: Adiponectin in a native Canadian population experiencing rapid epidemiology transition (Abstract). Diabetes 53 (Suppl. 1):947P, 2003
15. Valsamakis G, Chetty R, Mc Ternan PG, Al-Daghri NM, Barnett AH, Kumar S: Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 5:131-135, 2003
16. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relation ship of adiponectin to body fat distribution insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469, 2003
17. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999
18. Nishizawa H, Shimonura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734-2741, 2002
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
20. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH: International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-1 and B: IV. Comparability of apolipoprotein B values by use of international reference materials. Clin Chem 40:586-592, 1994